Bora Pharmaceuticals Co., LTD. (TPE:6472)
621.00
+3.00 (0.49%)
Oct 31, 2025, 2:36 PM CST
TPE:6472 Revenue
Bora Pharmaceuticals Co., LTD. had revenue of 4.87B TWD in the quarter ending June 30, 2025, with 10.20% growth. This brings the company's revenue in the last twelve months to 21.32B, up 57.27% year-over-year. In the year 2024, Bora Pharmaceuticals Co., LTD. had annual revenue of 19.25B with 35.53% growth.
Revenue (ttm)
21.32B
Revenue Growth
+57.27%
P/S Ratio
3.62
Revenue / Employee
n/a
Employees
36
Market Cap
77.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 19.25B | 5.05B | 35.53% |
| Dec 31, 2023 | 14.20B | 3.71B | 35.31% |
| Dec 31, 2022 | 10.49B | 5.59B | 114.18% |
| Dec 31, 2021 | 4.90B | 3.10B | 172.28% |
| Dec 31, 2020 | 1.80B | 270.35M | 17.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lotus Pharmaceutical | 19.12B |
| PharmaEssentia | 12.63B |
| Pegavision | 6.90B |
| Sunmax Biotechnology | 1.95B |
| Center Laboratories | 1.60B |
| Oneness Biotech | 112.57M |
| Polaris Group | 64.02M |
| Caliway Biopharmaceuticals | 44.83M |